<乌鸦传媒>Another Online SARMs Retailer Gets a Warning From the FDA Warrior Labz SARMS markets several drugs they claim could address weight loss, muscle growth Jun 22, 2023
<乌鸦传媒>Massive Kidney Stone Sets New Record Surgeons in Sri Lanka removed the record-setting stone earlier this month Jun 21, 2023
<乌鸦传媒>Cystic Renal Masses Often Harbor High-Grade Disease No link between grade and cancer-specific survival, active surveillance still an option for many Jun 16, 2023
<乌鸦传媒>No Increase in Major Cardiac Events With Testosterone-Replacement Therapy Men with hypogonadism and heart disease or risk factors saw no increased risk vs placebo Jun 16, 2023
<乌鸦传媒>FDA OKs Over-the-Counter Gel for Erectile Dysfunction Nonprescription topical showed 10-minute onset of action in clinical trials Jun 12, 2023
<乌鸦传媒>Airlines Need to Let Wheelchair Users Use Them on Planes, AMA Members Say Rescheduling testosterone also under discussion at annual meeting Jun 12, 2023
<乌鸦传媒>AMA Urged to Do More to Safeguard Adolescent Gender-Affirming Care Association needs to move from passive support to proactive protection, delegate says Jun 11, 2023
<乌鸦传媒>States Must Stop Criminalizing Medicine, AMA Delegates Say "This is unacceptable...and it's time for us to push back" Jun 11, 2023
<乌鸦传媒>FGFR Inhibitor Stakes Claim to Post-Anti-PD-1 Role in Advanced Bladder Cancer Survival benefit supports FGFR testing for all patients with metastatic disease, researcher says Jun 07, 2023
<乌鸦传媒>FDA OKs Olaparib-Abiraterone for Metastatic Prostate Cancer Approval limited to BRCA-positive subset Jun 01, 2023
<乌鸦传媒>'Practice Changing' Trial on Activity Recs After Prolapse Surgery In randomized study, noninferior outcomes for expedited activity versus standard wait of 6 weeks May 31, 2023
<乌鸦传媒>Lumpers vs Splitters: Categorizing Prostate Cancer Should very low-risk and low-risk be combined into one? May 19, 2023
<乌鸦传媒>Tainted 'Male Enhancement' Pills; Green Card Freeze Hits Nursing; Monkeypox Rebounds Health news and commentary from around the Web gathered by 乌鸦传媒 staff May 15, 2023
<乌鸦传媒>The Patient Case Against Requiring Medical Chaperones What sounds good in theory falls short in practice May 07, 2023
<乌鸦传媒>Snipless Vasectomy Shows Early Promise as Long-Term Male Contraceptive Hydrogel occlusion of vas achieves azoospermia quickly, maintained for a month May 03, 2023
<乌鸦传媒>Platelet-Rich Plasma Injections Flop for Erectile Dysfunction in U.S. Study Results from randomized trial contradict those seen in two European studies May 02, 2023
<乌鸦传媒>Novel Chemo Delivery System Achieves High Response Rate in Bladder Cancer Complete responses in 73% of patients with BCG-unresponsive non-muscle-invasive disease May 02, 2023
<乌鸦传媒>Upfront Systemic Therapy, Deferred Surgery Pass Muster in Advanced Kidney Cancer Two studies suggest no harm from deferred cytoreduction, potential benefits of immunotherapy May 02, 2023
<乌鸦传媒>Sublingual Vaccine Shows Promise in Women With Recurrent UTIs 40% of women who received a 3-month course of MV140 had no UTIs during 9-month follow-up May 01, 2023
<乌鸦传媒>More Men Are Expressing Interest in Vasectomy After SCOTUS Abortion Decision Vasectomy consults more than doubled in the 3 months after Dobbs compared with the year before May 01, 2023
<乌鸦传媒>Erectile Dysfunction Drugs May Have Major Cardiovascular Benefits PDE5 inhibitors lowered risk of CHF, MI, overall mortality in men with ED and CVD Apr 30, 2023
<乌鸦传媒>Enzalutamide-ADT Cuts Risk for Disease Spread in Nonmetastatic Prostate Cancer Combo has potential to be new standard of care in patients with high-risk BCR, expert says Apr 30, 2023
<乌鸦传媒>FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
<乌鸦传媒>Sperm Donor Banned Over Incest Fears; COVID Hampered Teen Sex; Jerry Springer Dies Health news and commentary from around the Web gathered by 乌鸦传媒 staff Apr 28, 2023
<乌鸦传媒>CAR T-Cell Therapy Shows Promise in Advanced Kidney Cancer ORR of 30% in patients with CD70-positive disease using off-the-shelf, allogeneic product Apr 19, 2023
<乌鸦传媒>Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
<乌鸦传媒>Older Men Still Overscreened for Prostate Cancer, Survey Says PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
<乌鸦传媒>FDA Greenlights New First-Line Regimen in Bladder Cancer Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
<乌鸦传媒>Post-Immunotherapy Combo Promising in Advanced RCC Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
<乌鸦传媒>Neuromodulation of the Peroneal Nerve Safe for Overactive Bladder Was also as effective as solifenacin in the majority of assessed efficacy endpoints Mar 24, 2023
<乌鸦传媒>Treating Gender Nonconforming Youth Goes Beyond the Physical We must approach care for every patient from the lens of treating the entire individual Mar 15, 2023
<乌鸦传媒>Gender-Affirming Surgery Gets a Boost After California Law Kicked In Nondiscrimination law bars insurers from limiting benefits based on gender identity, expression Mar 14, 2023
<乌鸦传媒>Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
<乌鸦传媒>A Surge in Vasectomies: Sustaining the Demand To increase participation, let's reduce the points of friction Mar 13, 2023
<乌鸦传媒>Daily Thiazide No Help in Preventing Recurrent Kidney Stones Three different dosages of hydrochlorothiazide no better than placebo Mar 01, 2023
<乌鸦传媒>Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subset Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
<乌鸦传媒>FDA OKs Sparsentan for IgA Nephropathy-Related Proteinuria Non-immunosuppressive therapy led to 50% reduction in proteinuria Feb 21, 2023
<乌鸦传媒>Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
<乌鸦传媒>Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomy But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
<乌鸦传媒>Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPC Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
